PURE · Pure Bioscience, Inc.
Market Cap
$11.70M
Shares
130.02M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$2.2M
+12.4%
FY2025
Net Income
-$2.4M
+28.4%
FY2025
Gross Margin
59.28%
+0.4pp
FY2025
Operating Margin
-103.37%
+59.8pp
FY2025
Diluted EPS
-$0.02
+33.3%
FY2025
Operating Cash Flow
-$2.02M
+20.4%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $2.42M | $2.2M | $1.96M | $1.87M | $1.81M | $3.7M | $6.92M | $1.91M | $1.77M | $1.83M | — | — | — | — | $812K | $464K | |
| $997K | $899K | $811K | $906K | $853K | $1.85M | $2.9M | $728K | $763K | $760K | $441K | $285K | $344K | $565K | $264K | $131K | |
| $1.43M | $1.3M | $1.15M | $971K | $1M | $2.08M | $4.02M | $1.18M | — | — | — | — | — | — | — | — | |
| — | 59.28% | 58.93% | 51.9% | 55.16% | 56.11% | 58.13% | 61.86% | — | — | — | — | — | — | — | — | |
| $312K | $316K | $302K | $297K | $319K | $339K | $322K | $354K | $459K | $779K | $927K | $790K | $1.03M | $1.17M | $1.86M | $2.18M | |
| $3.03M | $3.26M | $3.98M | $4.3M | $4.05M | $4.05M | $3.7M | $6.42M | $5.24M | $5.23M | $5.08M | $4.91M | $5.06M | $5.15M | $7.44M | $6.52M | |
| — | — | — | — | — | $75K | $75K | $135K | $179K | $178K | — | $179K | $177K | $188K | $206K | $186K | |
| — | $2000 | $148K | $117K | $213K | $172K | $192K | $241K | $285K | $276K | $219K | $206K | $248K | $311K | $385K | $471K | |
| — | — | — | — | — | — | — | — | — | — | — | — | $2.75M | — | — | — | |
| $3.34M | $3.58M | $4.34M | $4.91M | $4.72M | $4.39M | $4.02M | $6.77M | $8.82M | $7.84M | $8.35M | $8.37M | $12.45M | $8.16M | $9.57M | $8.83M | |
| -$1.92M | -$2.27M | -$3.19M | -$3.94M | -$3.72M | -$2.31M | $4000 | -$5.59M | -$7.04M | -$6.01M | -$7.06M | -$7.64M | -$11.9M | -$7.34M | -$8.75M | -$8.37M | |
| — | -103.37% | -163.22% | -210.74% | -205.41% | -62.49% | 0.06% | -292.77% | -396.96% | -328.13% | — | — | — | — | -1078.08% | -1803.23% | |
| — | -$2.27M | -$3.04M | -$3.83M | -$3.51M | -$2.14M | $196K | -$5.35M | -$6.76M | -$5.73M | -$6.84M | -$7.43M | -$11.65M | -$7.03M | -$8.37M | -$7.9M | |
| $390K | $299K | $155K | $14K | $6000 | $4000 | $5000 | $6000 | $8000 | — | — | $8000 | $10K | — | — | — | |
| $0 | — | — | — | — | — | — | — | — | — | — | — | — | — | $1000 | $8000 | |
| -$289K | -$127K | -$159K | -$18K | $233K | -$8000 | $5000 | -$965K | -$400K | -$255K | -$7.31M | $13K | $852K | -$332K | -$136K | $18K | |
| — | $0 | $0 | $0 | $1650 | $1650 | $1650 | $1650 | $1650 | $1650 | $1600 | $1600 | — | — | — | — | |
| -$2.21M | -$2.4M | -$3.35M | -$3.96M | -$3.49M | -$2.32M | $4000 | -$6.55M | -$7.44M | -$6.26M | -$14.37M | -$7.63M | -$11.05M | -$7.67M | -$8.89M | -$8.35M | |
| — | -109.14% | -171.36% | -211.7% | -192.55% | -62.71% | 0.06% | -343.32% | -419.5% | -342.05% | — | — | — | — | -1094.83% | -1799.35% | |
| USD/shares | -$0.01 | -$0.02 | -$0.03 | -$0.04 | -$0.04 | -$0.03 | $0.00 | -$0.09 | — | — | — | — | — | — | — | — |
| USD/shares | -$0.01 | -$0.02 | -$0.03 | -$0.04 | -$0.04 | -$0.03 | $0.00 | -$0.09 | — | — | — | — | — | — | — | — |
| shares | — | 111.86M | 111.86M | 111.4M | 88.84M | 87.17M | 82.21M | 72.88M | 67.28M | 63.49M | 56.83M | 39.75M | 25.61M | 10.84M | 5.62M | 4.67M |
| shares | — | 111.86M | 111.86M | 111.4M | 88.84M | 87.17M | 84.61M | 72.88M | 67.28M | 63.49M | 56.83M | 39.75M | 25.61M | 10.84M | 5.62M | 4.67M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Household & Personal Products median 1.72×
EV/EBIT
—
Household & Personal Products median 25.31×
P/E (TTM)
—
Household & Personal Products median 27.89×
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| PURE Hard Surface | $1,995,000 | $1,858,000 | $1,786,000 | $1,498,000 | $3,563,947 |
| SilVerion | $203,000 | $97,000 | $85,000 | $315,000 | $134,053 |
| Royalty | $4,000 | $8,000 | $6,000 | $40,000 | $229,000 |